Skip to main content

Table 1 Test systems

From: Systematic exploration of multiple drug binding sites

#

PDB IDa

Target

Ligand

MWb

1

3ptb

bovine β-trypsin

benzamidine

120

2

3n3 l

farnesyl pyrophosphate synthase

(6-methoxy-1-benzofuran-3-yl) acetic acid (MS0)

206

3a

3hvc

mitogen-activated protein kinase

4-[3-(4-fluorophenyl)-1 h-pyrazol-4-yl]pyridine (GG5)

239

3b

4f9w

mitogen-activated protein kinase

4-[3-(4-fluorophenyl)-1 h-pyrazol-4-yl]pyridine (GG5)

239

4

3cpa

carboxy-peptidase

GY

256

5

1qcf

haematopoetic cell kinase (HCK)

1-ter-butyl-3-p-tolyl-1 h-pyrazolo[3,4-d]pyrimidin- 4-ylamine (PP1)

281

6

1h61

pentaerythritol tetranitrate reductase

Prednisone®

358

7

2bal

mitogen-activated protein kinase

[5-amino-1-(4- Fluorophenyl)-1H-Pyrazol-4- yl] [3-(piperidin-4-yloxy) phenyl]methanone

380

8

1hvy

thymidylate synthase

Ralitrexed®

459

9

3g5d

tyrosine-protein kinase Src

Dasatinib®

488

10

1be9

PDZ-domain

KQTSV

544

  1. aPDB ID of the holo X-ray structure
  2. bMolecular weight of the ligand